CUV 1.61% $14.68 clinuvel pharmaceuticals limited

Ann: Clinuvel commences US Phase III trial of SCE, page-8

  1. 2,941 Posts.
    re: Ann: Clinuvel commences US Phase III tria... With your knowledge, I feel this product has shown that it safe and appears to be looking good for approval.
    Would you agree, or is it still a big possibility that they decline it?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.